studies in women with HIV show no increase In women with RMD who are at increased risk for osteoporosis from glucocorticoid use or underlying disease, we conditionally recommend against using DMPA as a longterm contraceptive because data suggest that bone mineral density declines by up to 7.5% over 2 years of use in a healthy population Although there are no published data suggesting increased fracture risk, the American College of Obstetricians and Gynecologists recommends caution regarding